Tomomi Fujii

Nara Medical University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Tomomi Fujii is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with renal cell carcinoma, particularly through minimally invasive techniques. Her most cited work investigates the critical impact of intraoperative tumor capsule injury (TCI) during robot-assisted and laparoscopic partial nephrectomy. By demonstrating that TCI can compromise oncological outcomes, Dr. Fujii has provided surgeons with actionable insights to refine their intraoperative techniques and reduce the risk of tumor spillage. This research, published in 2025 and already garnering 2 citations, underscores her commitment to improving surgical precision and patient prognosis. Her contributions are shaping best practices in nephron-sparing surgery, directly influencing how surgeons approach complex partial nephrectomies to balance cancer control with renal function preservation. Dr. Fujii’s work is essential reading for urologic surgeons and researchers seeking to advance the safety and efficacy of minimally invasive renal cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Intraoperative tumor capsule injury in patients with renal cell carcinoma receiving partial nephrectomy
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Nara Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago